Skip to main content
. Author manuscript; available in PMC: 2023 Apr 21.
Published in final edited form as: Transplant Cell Ther. 2022 Nov 25;29(3):151–163. doi: 10.1016/j.jtct.2022.11.015

Table 5.

Definitions of Multiorgan Dysfunction in TA-TMA

Organ Manifestations
Renal ≥50% reduction in GFR from pre-HCT conditioning value calculated by serum creatinine or cystatin-C or increase in serum creatinine ≥2 times baseline
Pulmonary Any need for positive-pressure ventilation (noninvasive or invasive) for ≥24 hours in the absence of definite etiology (i.e., adenovirus pneumonia, fluid overload, or severe sepsis), diffuse alveolar hemorrhage
Cardiovascular Pulmonary hypertension diagnosed by a cardiologist using cardiac catheterization, or pulmonary hypertension diagnostic criteria on echocardiography
Serositis Clinically significant serositis (pleural or pericardial effusions or ascites) requiring medical therapy (ie, diuretics) or drainage in the absence of other causes (eg, VOD/SOS, congestive heart failure)
Central nervous system Confusion, altered mental status, seizures with or without imaging evidence of posterior reversible encephalopathy syndrome (PRES)
GI GI bleeding and/or intestinal strictures requiring medical or surgical interventions

Multiorgan dysfunction as defined by Jodele et al.1,2